HENNEMAN JOHN B III — SEC Form 4 filings
SEC reporting owner CIK 1187572. 14 Form 4 filings on record with FilingPulse; latest filed 2026-06-23.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-03-14 to 2026-06-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 3 filings — 16,860 shares, $184,624 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
- Largest priced transaction: purchase of 5,000 shares @ $14.66 ($73,320) in Anika Therapeutics, Inc., filed 2026-05-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | Director | 4 | 1 leg · 5,000 sh · $73,320 | — | 3 |
| Orthofix Medical Inc. (OFIX) | Director | 4 | 1 leg · 5,000 sh · $61,295 | — | 3 |
| Aprea Therapeutics, Inc. (APRE) | Director | 4 | 1 leg · 6,860 sh · $50,009 | — | 8 |
| R1 RCM Inc. /DE (RCM) | Director | 2 | — | — | 3 |
Form 4 filings — HENNEMAN JOHN B III
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-23 | 4 | Anika Therapeutics, Inc. (ANIK) | Grant/award (A): 10,402 @ $0 | EDGAR |
| 2026-06-17 | 4 | Aprea Therapeutics, Inc. (APRE) | Grant/award (A): 3,135 @ $0 · Grant/award (A): 12,555 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Orthofix Medical Inc. (OFIX) | Grant/award (A): 14,965 @ $0 | EDGAR |
| 2026-05-08 | 4 | Orthofix Medical Inc. (OFIX) | Purchase (P): 5,000 @ $12.26 | EDGAR |
| 2026-05-04 | 4 | Anika Therapeutics, Inc. (ANIK) | Purchase (P): 5,000 @ $14.66 | EDGAR |
| 2025-06-24 | 4 | Anika Therapeutics, Inc. (ANIK) | Grant/award (A): 14,164 @ $0 | EDGAR |
| 2025-06-23 | 4 | Orthofix Medical Inc. (OFIX) | Grant/award (A): 18,841 @ $0 | EDGAR |
| 2025-06-09 | 4 | Aprea Therapeutics, Inc. (APRE) | Grant/award (A): 1,045 @ $0 · Grant/award (A): 4,185 (derivative) @ $0 | EDGAR |
| 2024-11-19 | 4 | R1 RCM Inc. /DE (RCM) | Disposition to issuer (D): 87,765 @ $14.30 · Disposition to issuer (D): 515,715 (derivative) | EDGAR |
| 2024-07-11 | 4 | Anika Therapeutics, Inc. (ANIK) | Grant/award (A): 5,771 @ $0 | EDGAR |
| 2024-06-21 | 4 | Aprea Therapeutics, Inc. (APRE) | Grant/award (A): 1,045 @ $0 · Grant/award (A): 4,185 (derivative) @ $0 | EDGAR |
| 2024-06-20 | 4 | Orthofix Medical Inc. (OFIX) | Grant/award (A): 15,152 @ $12.87 | EDGAR |
| 2024-05-23 | 4 | R1 RCM Inc. /DE (RCM) | Grant/award (A): 15,651 @ $0 | EDGAR |
| 2024-03-14 | 4 | Aprea Therapeutics, Inc. (APRE) | Purchase (P): 6,860 @ $7.29 · Purchase (P): 3,430 (derivative) · Purchase (P): 3,430 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1187572 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →